Approaches in mammalian synthetic biology have transformed how cells can be programmed to have reliable and predictable behaviour. The majority of mammalian synthetic biology has been accomplished using immortalized cell lines that are easy to grow, and easy to transfect. Additionally, genetic circuits that integrate into the genome of these immortalized lines remain functional for many generations, often for the lifetime of the cells. However, when genetic circuits are integrated into the genome of stem cells, gene silencing is observed within a few generations. To investigate the stability of genetic circuits and their propensity to silence in stem cells, the Rosa26 locus of mouse pluripotent stem cells was modified to contain docking sites for site-specific integration of genetic circuits. We show that the silencing of genetic circuits can be reversed with the addition of sodium butyrate, a histone deacetylase inhibitor. These findings demonstrate an approach to stabilize the function of genetic circuits in pluripotent stem cells to ensure robust function over many generations. Altogether, this work introduces an approach to overcome silencing of genetic circuits in pluripotent stem cells that enable the possibility of leveraging synthetic biology in pluripotent stem cells to meet therapeutic needs.
INTRODUCTION
Pluripotent stem cells have the potential to augment tissue regeneration, in addition to creating cellspecific in vitro diagnostics and drug screens because they are capable of self-renewing and differentiating into any cell type (1) . Induced pluripotent stem (iPS) cells can be derived from mature tissue cells from individuals by expressing key transcription factors, which has the potential to facilitate personalized medicine (2) . However, despite advances in stem cell culture techniques, differentiation can be inefficient, laborious, expensive, or otherwise intractable (3, 4) . It has been proposed that programming reliable cell behaviour using approaches in synthetic biology can be used for directing cell fate decisions to enhance their therapeutic potential. For example, using genetic circuits to reprogram cells to facilitate precise gene regulation can be used to enhance cell differentiation outcomes for tissue engineering and regenerative medicine applications. Moreover, in order to capitalize on the tight gene control of genetic circuits, their stability in the genome, or ability to maintain function, for many generations is critical.
Novel genetic tools built by synthetic biologists have transformed how cells can be reprogrammed that include genetic programs to introduce switching (5) (6) (7) (8) (9) (10) (11) (12) , oscillations (13) (14) (15) (16) (17) (18) , logic gates (19) (20) (21) , and biosensing (22) (23) (24) (25) (26) (27) (28) behaviours into cells. Assembling simple genetic parts into more complex gene circuits can reliably and predictably control cell behaviours (29, 30) . To date, the majority of mammalian synthetic biology has taken place in easy-to-grow and easy-to-transfect cells, derived from immortalized cell lines. These model cell lines are useful for enhancing our understanding of synthetic gene circuits that underscore the potential of synthetic biology tools, however, these cell lines may not be good predictors of the challenges that arise in stem cells (31) . Plasmid and viral gene delivery systems have shown to lose expression over weeks of cell culture, which is thought to be a consequence of epigenetic modifications of the inserted DNA (32) (33) (34) . The current understanding of transgene silencing suggests that silencing of genes can occur through the methylation of the expression cassette and/or the formation of heterochromatin, both of which facilitate changes in gene expression; however, the circumstances that trigger these mechanisms are still being elucidated. To overcome these challenges, several strategies to mitigate the effects of transgene silencing have been used, such as the inclusion of universal chromatin opening elements (35, 36) , scaffold/matrix attachment regions (37) , CG free plasmid backbones (38) , minicircle DNA (39), genomic insulators (40) , and targeted integration in open chromatin regions (41) . These approaches can significantly lessen transgene silencing, however the effects are not universal (42, 43) . Currently, the impact of genetic circuit silencing is not known, and strategies to alleviate silencing have yet to be explored.
Genetic circuits are distinct from plasmid and viral expression cassettes because they contain multiple genetic modules that makeup the circuits, resulting in larger DNA constructs that need to be inserted into cells. Since genetic circuits endow cells with tight gene control, they have been a focus for directing stem cell fate to enable both timed and tuned gene expression that match the evolving requirements of the differentiating cells as they undergo cell fate decisions (44) . Altogether, reliable stem cell programming with genetic circuits will require tools that integrate into the genome, have predictable expression patterns in differentiated cells, and avoid disruption of endogenous genes and pathways.
One potential approach to avoid epigenetic silencing of integrated genetic circuits is to engineer genomic safe harbour sites within the genome that support the integration of genetic material to those specific genomic locations, or loci. Additionally, safe harbour loci within the genome limit transgene silencing caused by unpredictable genome interactions associated with random insertions (32, 45) .
The Rosa26 locus in mice has been observed to facilitate the ubiquitous expression of transgenes in developing and adult tissue when inserted at this site, suggesting that transgenes are active in germ cells, in addition to the differentiated progeny of those cells (46, 47) . Therefore, the Rosa26 locus is an ideal location to target for inserting genetic circuits to study their stability and function, in stem cells.
Here, genetic circuit silencing was studied by observing circuit function in pluripotent stem cells by engineering a mouse embryonic stem (ES) cell line with three fC31 docking sites on one allele of the Rosa26 locus to function as a landing pad for large genetic circuits that have a matching recombinase.
The genetic circuit, LTRi, was chosen because it is relatively complex in architecture and the genetic circuit permits tuneable control of gene expression (7, 48, 49) .
MATERIAL AND METHODS

Design of plasmids
The homology repair template for CRISPR was Gibson assembled to include 1kb homology arms, an 
CRISPR modified pluripotent stem cells
Plasmid DNA containing the repair template with three tandem attP sites was co-transfected (1:1, Jetprime VWR#89129) with a plasmid containing Rosa26-Cas9/gRNA into mouse ES cells when confluency reached 70%. The cells were selected by adding 200µg/ml neomycin (G418 Life Technologies #10131035) to the growth medium. Resistant clones were expanded and screened for the on-site genomic edit by genomic PCR. Copy number qPCR (Power Sybr, Thermofisher #4368577) was used to determine off-site integration. The neomycin resistance gene was removed by transfecting and flow sorting (Beckon Dickenson FACSAria) the candidate cell line with a plasmid harboring GFP-flip recombinase and assessing the reacquisition of neomycin sensitivity.
Docking plasmids
mLTRi-GFP cell lines were established by co-transfection with C31 integrase in the 3X-attP AB2.2 ES cells. Cells that had the mLTRi-GFP plasmid contained a neomycin resistant cassette so these transfected ES cells were selected by G418, and resistant lines were clonally expanded and further screened by inducibility with 250 M IPTG. One of the positive clones was chosen and used for the entire study reported here.
Quantitative PCR primer design
All primers were design with NCBI's primer blast to have a PCR product size between 70bp and 200bp and a melting temperature between 58°C and 62°C (Table S1 ). The primers for known copy number (GAPDH and ZFY1) were design to not span and exon junction because the template was genomic DNA. The primers were tested to ensure that there was no alignment with non-specific sequences. Each primer was tested using a 2x dilution of genomic DNA to ensure a single melting curve peak to ensure specific binding to only the desired location.
Quantitative PCR
Genomic DNA was isolated from the ES cells using lysis buffer (100mMTris-Cl, 5mM EDTA, 200mM NaCl, 0.2% SDS) and proteinase K as previously reported (50) . The DNA was then precipitated in C2H3NaO2 and isopropanol and washed in EtOH. After genomic DNA elution and quantification using a NanoDrop (ThermoFisher) and a 1ng/µl stock was created. From the 1ng/ul stock a 2x dilution was prepared for each qPCR experiment. Each well of the qPCR reaction contained: 10ul of Power SYBR 
RESULTS
Generation of fC31 docking sites in the Rosa26 locus of pluripotent stem cells
Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology enable the targeting of specific locations within the genome. Utilizing CRISPR/Cas9 with customized guide RNAs (gRNAs) to target specific locations within the genome offers a useful method for engineering landing pads for genetic circuits at desired locations within the genome. Indeed, CRISPR/Cas9 can be used for inserting new sequences of DNA, however, the efficiency is significantly decreased when inserting DNA sequences larger than 5kb (51) . Because most genetic circuits that function in mammalian cells are larger than 5kb, inserting a landing pad that has a site-specific recombinase can increase efficiency of integration of these larger DNA constructs into the genome when a matching recombinase is present in the plasmid containing the DNA to be inserted (52).
To allow for targeted and efficient integration of genetic circuits into the genome of pluripotent stem cells, fC31 docking sites were inserted into the Rosa26 locus ( Figure 1A ) of mouse ES cells using CRISPR/Cas9 technology. Three tandem fC31 integrase attP sites were inserted that serve as a landing pad for larger DNA additions containing an attB sequence (47) . To create an efficient screening method, a neomycin resistance gene flanked by FRT sites was added upstream of the 3x attP sites inside the homology arms of the repair DNA plasmid, and outside of the arms, a blue fluorescent protein (BFP) cassette was included ( Figure 1B ). This plasmid was co-transfected with Cas9 endonuclease and a gRNA that targets the Rosa26 locus. Adding neomycin (G418) to the media of transfected cells enables for the selection of ES colonies that have the landing pad integrated into the genome at the Rosa26 locus ( Figure 1C ). CRISPR/Cas9 technology has shown to have off target effects, namely whole or parts of the repair template integrate into the genome at random locations, rather than just the repair DNA flanked by the homology arms in the targeted location (53) (54) (55) (56) . To screen for off-target insertions, a BFP cassette was added outside of the homology arms in the repair DNA template ( Figure 1B) . Therefore, any ES colony expressing BFP would indicate that the repair plasmid was incorrectly integrated into the genome and discarded. The ES cells resistant to G418 that did not express BFP were selected and verified by PCR for the on-site insertion of attP sites in the Rosa26 locus with primers designed to span part of the neomycin resistance gene and the genomic DNA beyond the homology arm ( Figure 2A ). ES clones with an onsite edit produced a 1.6kb amplicon ( Figure 2B ) that contained an XbaI site and when isolated and cut with XbaI endonuclease produced the predicted 1.1kb and 500bp bands ( Figure 2C ). DNA sequencing was also performed and further confirmed the insertion of the repair DNA in the Rosa26 locus.
Screen of the mouse genome for correct genomic edits
To assess the number of docking sites integrated into the mouse genome, quantitative PCR (qPCR) was performed to verify whether additional integrations occurred elsewhere within the genome ( Figure   2D ). By referencing two genes of known copy number, ZFY1 on the Y chromosome (one copy), and GAPDH on chromosome 6 (two copies), it was possible to determine how many times the docking site was inserted into the genome. Primers were designed to anneal at the end of the 3x attP sequence and included part of the genomic Rosa26 sequence to give a ~100mer amplicon ( Figure   2A ). The mean CT values of each primer set vs. the log of DNA (ng) were plotted as previously described (50) . The slope of CT values vs. log of DNA of each sample was calculated and compared to the slope of ZFY1 and GAPDH. Since the slope of the attP amplicon matched that of the ZFY1, it
shows that the docking site was added once ( Figure 2D ). Once correct docking was confirmed, the neomycin resistance gene was removed by transfecting the confirmed heterozygous ES line with a plasmid harboring flip recombinase, leaving the 3x attP sites ( Figure 2E ). To validate that the resistant cassette was removed, the FLP transfected ES cells were clonally expanded, assessed for neomycin sensitivity, and verified by PCR. The amplification of the wild type ES Rosa26 locus is expected to be 1.1kb, while the addition of the attP sites without neomycin is expected to increase in size to 1.4kb
( Figure 2F ). Results indicate that the ES cell line has the Rosa26 site-specific addition of 3x attP sites at one allele and is nowhere else in the genome.
Docking genetic circuits
To assess the stability LTRi_EGFP in pluripotent stem cells, the genetic circuit was integrated into the Rosa26 locus at the docking sites. First, to rule out the possibility of CMV and RSV being silenced (57), LTRi was modified to replace the original CMV and RSV promoters with the non-viral promoters mouse Elongation Factor-1 (mEF1), and rat Elongation Factor-1 (rEF1) (Figure 3A-B) . Site-specific docking of the modified LTRi (mLTRi)_EGFP genetic circuit was accomplished by adding an attB sequence to the plasmid. Along with the genetic circuit, the plasmid also contained a neomycin resistance cassette for G418 selection of transfected ES cells. The mLTRi genetic circuit containing an attB sequence was co-transfected with fC31 integrase, resulting in the mLTRi genetic circuit stably integrated into the genome. ES cells resistant to G418 were clonally expanded and screened for their response to the chemical inducer, isopropyl b-D-1-thiogalactopyranoside (IPTG), a small molecule that activates gene expression of the genetic circuit (7, 48, 49) . To confirm docking, the IPTG responsive cell lines were screened for integration into Rosa26 by conventional PCR with primers flanking the Rosa locus and the genetic circuit, which is expected to produce a 1.3kb amplicon ( Figure   S1A and B).
Assessing the stability of genetic circuits in Rosa26 locus
To investigate the stability of the mLTRi genetic circuit in pluripotent stem cells, mLTRi was docked into the Rosa26 locus of mouse ES cells and the cells expressing EGFP in the presence of IPTG were single cell sorted and cultured for more than three weeks in the presence or absence of IPTG.
EGFP was assessed using microscopy and results show that ES colonies that are cultured beyond three weeks significantly lose their ability to express EGFP in the presence of IPTG compared to cells in earlier time points ( Figure 3C-D' ). Altogether, these data suggest that the decrease in gene expression strength is likely due to the genetic circuit being susceptible to epigenetic modifications, specifically to methylation and/or histone acetylation (33, 34, 58) .
Reactivation of silenced mLTRi in pluripotent stem cells
To investigate the epigenetic silencing of mLTRi, two common mechanisms of transgene silencing that are frequently cited as barriers when introducing exogenous DNA were studied. The first, promoter methylation, occurs with the methylation of cytosine residues in CpG sequences by the cytosine DNA methyltransferase (DNMT1) enzyme that can be reversed with methyltransferase inhibitor 5-aza-deoxycytidine (AzaC) (59) (60) (61) (62) (63) (64) . The second, histone acetylation, is a process where an acetyl group is added to a lysine residue on the tail of a histone by histone deacetylase, which can be prevented by sodium butyrate (NaB), a known histone deacetylase inhibitor (HDACi) (65) (66) (67) .
To test whether the silenced genetic circuit could be reactivated, ES colonies that lost their ability to respond to IPTG were grown in the presence of the inhibitors AzaC or NaB for 48 hours, and EGFP expression was assessed using flow cytometry ( Figure 4A ). In line with histone acetylation dependent silencing, EGFP expression was reactivated in the presence of NaB, suggesting that the genetic circuit was silenced by histone acetylation. Next, to determine the optimal concentration of NaB for recovering genetic circuit function, various concentrations of NaB were added to the media of silenced ES cells in the presence of 250µM IPTG ( Figure 4B ). While 5M NaB showed the most recovery of EGFP expression, cells grown in this condition stop growing after 24 hours and were dead after 48
hours. We found that the 500µM concentration of NaB also slowed the growth of the ES cells, and while they did not die after 48 hours, their morphology changed and the cells did not appear as healthy as the no NaB control. The 250µM concentration of NaB did not appear to alter the growth rate or the morphology of the ES cells over time. Therefore, we conducted our experiments at 250µM
NaB. To determine whether EGFP expression dynamics could be recovered, ES cells that recovered their EGFP expression in the presence of 250µM NaB were sorted by flow cytometry and grown in various concentrations of IPTG ( Figure 4C ) over various time points. These data show that exposure to 250µM NaB for 48 hours reverses the silencing of mLTRi_EGFP and allows for the recovery of the genetic circuit. This docking site functions as a landing pad for genetic circuits that have a matching recombinase to be targeted for insertion at this genome location. Docked mLTRi in this location demonstrated robust circuit function for up to three weeks of culture, however, after three weeks EGFP expression significantly decreased and mLTRi was no longer responsive to IPTG induction. To overcome this silencing in pluripotent stem cells, we show that adding the HDAC inhibitor, NaB, to the media reverses the silencing of the mLTRi genetic circuit and enables its original function to be rescued.
DISCUSSION
Taken together, this study demonstrates that genetic circuits can be inserted into the genome of pluripotent stem cells and if circuit function diminishes over time, NaB can be added to the growth media to re-establish circuit function. These data raise the exciting possibility of using synthetic biology in pluripotent stem cells for many therapeutic applications.
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